We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00118976
Recruitment Status : Completed
First Posted : July 12, 2005
Last Update Posted : November 23, 2006
Information provided by:
Steno Diabetes Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2006